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ABSTRACT 
Objective: COVID-19 caused by novel SARS-coronavirus 2 belonging to family Coronaviridae, is a global public health emergency infecting many 
people all around the world, especially in India with more than 2,98,000 cases. Hence there is a need for a novel drug that counters SARS-CoV2 is 
the prime requirement at this time.  
Methods: The present study aimed to assess bioactive compounds found in Azadirachta indica as a potential inhibitor of COVID-19 Mpr °(6Y2E, 
6LU7, and 2GTB) by Autodock 4.2, with the Lamarckian Genetic Algorithm. COVID-19 Mpr ° was docked with thirteen bioactive compounds, and 
docking was analyzed by Autodock 4.2 and Pymol. Nelfinavir and Saquinavir were used as positive standards for comparison.  
Results: Azadirachtanin, Azadirachtol, and Salannolide, were left out because of the violation of Lipinski’s rule. The binding energies obtained from the 
docking of 6Y2E with a native ligand, Azadiradione, Beta-sitosterol, Epiazadiradione, Epoxyazadiradione, Kaempferol, Meldenin, Myricetin, Nimbaflavone, 
Nimbinene, Nimbione, Nimbocinolide, Quercitrin, Vepnin, Saquinavir, and Nelfinavir were-7.32,-6.63,-6.69,-7.52,-5.27,-4.54,-6.07,-4.19,-5.02,-5.58,-6.23,-4.71, 
-3.72,-6.4,-7.14 and-4.67 kcal/mol respectively. The binding energies obtained from the docking of 6LU7 with the native ligand, Azadiradione, Nimbione, 
Vepnin, and Saquinavir were-6.14,-6.48,-6.79 and-6.49 kcal/mol correspondingly. The binding energies obtained from the docking of 2GTB with the native 
ligand, Azadiradione, Epiazadiradione, Epoxyazadiradione, Kaempferol, Meldenin, Myricetin, Nimbaflavone, Nimbione, Nimbocinolide, Quercitrin, Vepnin, 
Saquinavir, and Nelfinavir were-6.96,-7.13,-6.69,-5.22,-6.44,-5.06,-5.93,-6.66,-5.3,-5.63,-7.11,-6.89 and-5.42kcal/mol, respectively. 
Conclusion: Azadiradione, Epiazadiradione, Nimbione, and Vepnin seemed to have the greatest potential to act as COVID-19 protease inhibitors. 
However, further research is necessary to explore their prospective medicinal use in vitro and in vivo conditions. 
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INTRODUCTION 
The Coronavirus disease 19 (COVID 19) is a highly transmitted and 
pathogenic viral infection caused by the severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2), which started emerging in 
Wuhan, China and spread around the world [1, 2]. With an exemption of 
Antarctica, it is vigorously transmitted from Wuhan city to nearly every 
country in the world [3]. According to the World Health Organization 
(WHO) on 24 June 2020 around 91,29,146 cases of persons infected 
worldwide by COVID-19 out of which 4,73,797 death in 216 countries. 
Since COVID-19 is quickly spreading, the WHO has declared it as a 
pandemic disease [4]. Common symptoms of the corona virus-infected 
person have respiratory symptoms, fever, cough, shortness of breath, 
and dyspnea. In severe cases, an infection can cause pneumonia, severe 
acute respiratory syndrome, kidney failure, and even death [5, 6]. 
Presently there is no specific treatment for COVID 19. 
Coronaviruses are enveloped viruses with a positive RNA genome, 
belonging to the Coronaviridae family of the order Nidovirales, which are 
divided into four genera, namely α, β, γ, and δ [5]. The SARS-CoV-2 
belongs to the β genus. Coronavirus contains at least four structural 
proteins: Spike (S) protein, envelope (E) protein, membrane (M) protein, 
and nucleocapsid (N) protein [7]. Among that, Spike helps in host 
attachment and membrane fusion during the infection of the virus. 
Therefore, Spike determines to some extent of the host range [5]. The 
main protease (Mpro)/chymotrypsin-like protease (3CLpro) from 
COVID-19, which has been successfully crystallized, structured, and 
repositioned in the Protein Data Bank and this protease represents a 
potential target for the inhibition of Corona Virus replication [8]. 
Azadirachta indica (Neem) is a member of the Meliaceae family and its 
role in health-promoting outcome is recognized because of its 
antioxidant property and various other antimicrobial properties. It has 
been widely used in Chinese, Ayurvedic, and Unani medicines 
worldwide, especially in the Indian subcontinent in the treatment and 
prevention of various diseases [9]. Azadirachta indica has more than 140 
chemically active compounds isolated from its different parts, including 
i.e. seeds, roots, flowers, fruits, leaves, and bark and are used 
traditionally for curing many diseases. These active compounds have 
been identified as anti-mutagenic, anti-inflammatory, anti-oxidant, anti-
ulcer, anti-hyperglycaemic, immune-modulator, anti-carcinogenic, and 
anti-viral drugs [10]. Since COVID-19 is the highest outbreak in almost all 
nations, novel methodologies of drug strategy and discovery can be 
exploited as a promising tool for finding various therapeutic drug agents. 
In the present study, we observe the binding affinity of 16 ligands, 
which are present in Azadirachta indica for COVID-19 6LU7, 6Y2E 
proteases, and 2GTB. The main purpose of this study is to make use 
of recognized natural products to be used to strengthen defences 
against coronavirus by developing drugs based on natural products.  
MATERIALS AND METHODS 
Macromolecule (protein) and ligand 
The COVID-19 Mpro (PDB ID: 6LU7, 6Y2E, 2GTB) structures of the main 
protease were obtained from the Protein Data Bank 
(https://www.rcsb.org/) in. pdb format. The 6LU7 protein contains two 
chains, A and B, which form a homodimer. Chain A alone was taken for 
macromolecule preparation. Drug-like properties were calculated using 
Lipinski’s rule of five, which suggested that molecules with poor 
permeation and oral absorption have molecular weights>500, C logP>5, 
more than 5 Hydrogen-bond donors, more than 10 acceptor groups, 
more than 10 rotatable bonds, and Molar refractivity was not in the 
range between 40 and 130 [8, 11, 12]. Adherence to Lipinski’s rule of five 
was calculated using SWISSADME (http://www.swissadme.ch/). 
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Table 1: Properties of ligand molecules from Azadirachta indica 
S. No. Name of the ligand Molecular formula Lipinski’s rule of five 
Properties  Value 
1 Azadirachtanin C32H40O11 Molecular weight  600.65 g/mol 
Log P  3.82 
H–bond donor  2 
H–bond acceptor  11 
Molar refractivity  148.84 
Number of rotatable bonds 7 
Violations 3 
2 Azadirachtol C28H36O13 Molecular weight  580.58 g/mol 
Log P  2.81 
H–bond donor  4 
H–bond acceptor  13 
Molar refractivity  131.30 
Number of rotatable bonds 5 
Violations 3 
3 Azadiradione C28H34O5 Molecular weight  450.57 g/mol 
Log P  3.18 
H–bond donor  0 
H–bond acceptor  5 
Molar refractivity  125.48 
Number of rotatable bonds 3 
Violations 0 
4 Beta-sitosterol C29H50O Molecular weight  414.71 g/mol 
Log P  5.05 
H–bond donor  1 
H–bond acceptor  1 
Molar refractivity  133.23 
Number of rotatable bonds 6 
Violations 2 
5 Epiazadiradione C28H34O5 Molecular weight  450.57 g/mol 
Log P  3.11 
H–bond donor  0 
H–bond acceptor  5 
Molar refractivity  125.48 




Epoxyazadiradione C28H34O6 Molecular weight  466.57 g/mol 
Log P  3.32 
H–bond donor  0 
H–bond acceptor  6 
Molar refractivity  124.96 
Number of rotatable bonds 3 
Violations 0 
7 Kaempferol C15H10O6 Molecular weight  286.24 g/mol 
Log P  1.70 
H–bond donor  4 
H–bond acceptor  6 
Molar refractivity  76.01 
Number of rotatable bonds 1 
Violations 0 
8 Meldenin C28H38O5 Molecular weight  454.60 g/mol 
Log P  3.43 
H–bond donor  1 
H–bond acceptor  5 
Molar refractivity  126.91 
Number of rotatable bonds 3 
Violations 0 
9 Myricetin C15H10O8 Molecular weight  318.24 g/mol 
Log P  1.08 
H–bond donor  6 
H–bond acceptor  8 
Molar refractivity  80.06 
Number of rotatable bonds 1 
Violations 0 
10 Nimbaflavone C26H30O5 Molecular weight  422.51 g/mol 
Log P  4.36 
H–bond donor  2 
H–bond acceptor  5 
Molar refractivity  123.48 
Number of rotatable bonds 6 
Violations 0 
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11 Nimbinene C28H34O7 Molecular weight  482.57 g/mol 
Log P  3.68 
H–bond donor  0 
H–bond acceptor  7 
Molar refractivity  128.17 
Number of rotatable bonds 6 
Violations 0 
12 Nimbione C18H22O3 Molecular weight  286.37 g/mol 
Log P  2.24 
H–bond donor  1 
H–bond acceptor  3 
Molar refractivity  82.64 
Number of rotatable bonds 0 
Violations 0 
13 Nimbocinolide C32H42O10 Molecular weight  586.67 g/mol 
Log P  2.84 
H–bond donor  3 
H–bond acceptor  10 
Molar refractivity  150.48 
Number of rotatable bonds 6 
Violations 2 
14 Quercitrin C21H20O11 Molecular weight  448.38 g/mol 
Log P  1.60 
H–bond donor  7 
H–bond acceptor  11 
Molar refractivity  109.00 
Number of rotatable bonds 3 
Violations 2 
15 Salannolide C34H44O11 Molecular weight  628.71 g/mol 
Log P  3.65 
H–bond donor  1 
H–bond acceptor  11 
Molar refractivity  159.14 
Number of rotatable bonds 9 
Violations 3 
16 Vepnin C28H36O5 Molecular weight  452.58 g/mol 
Log P  3.50 
H–bond donor  0 
H–bond acceptor  5 
Molar refractivity  124.72 
Number of rotatable bonds 3 
Violations 0 
17 Saquinavir C38H50N6O5 Molecular weight  670.84 g/mol 
Log P  3.66 
H–bond donor  5 
H–bond acceptor  7 
Molar refractivity  192.87 
Number of rotatable bonds 16 
Violations 2 
18 Nelfinavir C32H45N3O4S Molecular weight  567.78 g/mol 
Log P  3.87 
H–bond donor  4 
H–bond acceptor  5 
Molar refractivity  166.17 
Number of rotatable bonds 12 
Violations 2 
 
The ligands for which the active compound present in Azadirachta indica 
were downloaded from Dr. Duke’s Phytochemical and Ethnobotanical 
Databases (https://phytochem.nal.usda.gov/phytochem/search/list). 
The ligands present in the study were Azadirachtanin, Azadirachtol, 
Azadiradione, Betasitosterol, Epiazadiradione, Epoxyazadiradione, 
Kaempferol, Meldenin, Myricetin, Nimbaflavone, Nimbinene, Nimbione, 
Nimbocinolide, Quercitrin, Salannolide, and Vepnin. The three-
dimensional structures of the selected ligands from Azadirachta indica 
were obtained from PubChem (https://pubchem.ncbi.nlm.nih.gov/) in. 
sdf format. The properties of ligand molecules chosen for the study were 
listed in table 1. Anti-HIV drugs, Saquinavir, and Nelfinavir were used as 
positive control. 
Molecular docking 
The protease files were prepared for, COVID-19 6LU7 protease, 
6Y2E protease, and 2GTB separately using Autodock 4.2. The 
macromolecule was prepared using ‘A’ chain of the protease, the 
water molecule was deleted, polar hydrogen atoms and charges 
were added. The file was saved in the. PDBQT format for further 
analysis. The grid box was used to obtain the X, Y, and Z coordinates. 
The ligand files in the. Mol 2 format was converted to the. PDBQT 
format by Open Babel after detecting the torsion root.  
Using the protease. PDBQT file, ligand. PDBQT file and the X, Y, and Z 
coordinates, binding affinity was calculated using Lamarckian 
genetic algorithms by AutoDock 4.2. The conformations were played 
ranked by energy. The hydrogen bonds were viewed and the 
complex was saved in pdbqt format and then converted to. pdb 
format. The 3D structure of the protease-ligand complex interaction 
was visualized using PyMOL, and the 2D structure of the molecular 
interaction was visualized using the Biovia Discovery Studio 2020 
Client. 
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RESULTS AND DISCUSSION 
Coronaviruses (CoVs) represented a major group of viruses, mostly 
affecting human beings through zoonotic transmission [13]. In the 
past two decades, this was the third occurrence of the emergence of 
a new coronavirus, after severe acute respiratory syndrome (SARS) 
in 2003 and Middle East respiratory syndrome coronavirus 
(MERSCoV) in 2012 [14, 15].  
2GTB was the main protease found in the coronavirus associated with 
the severe acute respiratory syndrome (SARS), which could be retrieved 
in PDB and was recommended to be a potential drug target for 2019-
nCov and it shared 96% similarity with that of SARS [16]. 6Y2E and 
6LU7 were the main protease found in Coronavirus and their structures 
were available in PDB. Ligands and anti-HIV compounds had been 
selected based on adherence to Lipinski’s rule of five. The selected 
ligands that had 2 or less than 2 violations of Lipinski’s rule were used in 
molecular docking experiments with the target proteins (6LU7 protease, 
6Y2E protease, and 2GTB). Azadirachtanin, Azadirachtol, and 
Salannolide were omitted because of the violation of Lipinski’s rule. The 
drug scanning outcomes (table 1) showed that 13 bioactive compounds 
and 2 positive controls used in this study were accepted by Lipinski’s 
rule of five. Table 2, 3, and 4 showed the molecular docking analysis 
results of bioactive compounds against 6Y2E, 6LU7, and 2GTB, 
respectively including binding energy/Gibbs Energy, inhibition constant, 
intermolecular energy, torsional energy and internal energy. Fig. 1, 2, 
and 3 showed 3D visualization of binding sites of various bioactive 
compounds from Azadirachta indica to the active sites of coronavirus 
protease 6Y2E, 6LU7, and 2 GTB. 
 
Table 2: Molecular docking analysis of bioactive molecules from Azadirachta indica against 6Y2E 








1 Azadiradione -7.32 4.34 -8.21 0.89 -1.17 
2 Beta-sitosterol -6.63 13.76 -8.72 2.09 -1.13 
3 Epiazadiradione -7.52 3.06 -8.42 0.89 -1.3 
4 Epoxyazadiradione -5.27 136.58 -6.17 0.89 -1.22 
5 Kaempferol -4.54 472.42 -6.03 1.49 -1.36 
6 Meldenin -6.07 35.26 -7.27 1.19 -1.51 
7 Myricetin -4.19 851.61 -6.28 2.09 -2.03 
8 Nimbaflavone -5.02 208.13 -7.41 2.39 -2.54 
9 Nimbinene -5.58 80.63 -7.37 1.79 -2.09 
10 Nimbione -6.23 27.13 -6.53 0.3 0.05 
11 Nimbocinolide -4.71 351.27 -7.4 2.68 -4.3 
12 Quercitrin -3.72 1890 -6.7 2.98 -4.03 
13 Vepnin -6.4 20.19 -7.3 0.89 -1.04 
14 Saquinavir -7.14 5.87 -10.72 3.58 39.33 
15 Nelfinavir -4.67 374.41 -8.25 3.58 -2.94 
 
Out of 13 compounds evaluated from Azadirachta indica the binding 
energies lesser than the upper threshold (-6Kcal/mol) were 
generally regarded as a cut-off in ligand binding studies [17, 18]. The 
binding affinity for protease 6Y2E ranged between-3.72 (Quercitrin) 
to-7.52 (Epiazadiradione). The binding affinities for protease 6Y2E 
were -7.32,-6.63,-6.07,-6.23, and -6.4 for Azadiradione, Beta-sitosterol, 
Meldenin, Nimbione, and Vepnin respectively. The binding energy of 
Saquinavir was-6.89. When comparing the values of binding 
energies, Epiazadiradione and Azadiradione had more binding 
energy than Saquinavir. 
 
 
Fig. 1: 3D Visualization of docking analysis of 6Y2E protease binding with 1. Azadiradione 2. Beta-sitosterol 3. Epiazadiradione 4. 
Meldenin 5. Nimbione 6. Vepnin 7. Saquinavir. The yellow dots represent hydrogen bonds 
 
Among the thirteen compounds evaluated from Azadirachta indica, 
the binding energies more than the upper threshold limit, of-
6Kcal/mol were only three. The binding affinity for protease 6LU7 
ranged between-2.84 (Quercitrin) to-6.79 (Vepnin). The binding 
affinities for protease 6LU7 were-6.14, and-6.48 for Azadiradione, 
and Nimbione respectively. The binding energy of Saquinavir was-
6.49. The binding affinities of these three compounds were 
reasonably compared well with that of Saquinavir. 
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Table 3: Molecular docking analysis of bioactive molecules from Azadirachta indica against 6LU7 








1 Azadiradione -6.14 31.51 -7.04 0.89 -1.27 
2 Beta-sitosterol -4.94 238.75 -7.03 2.09 -1.65 
3 Epiazadiradione -5.92 46.01 -6.81 0.89 -1.34 
4 Epoxyazadiradione -5.51 90.85 -6.41 0.89 -1.15  
5 Kaempferol -5.27 137.8 -6.76 1.49 -1.4 
6 Meldenin -5.05 197.21 -6.25 1.19 -2.12 
7 Myricetin -5.08 189.67 -7.17 2.09 -2.17 
8 Nimbaflavone -4.04 1100 -6.42 2.39 -1.94 
9 Nimbinene -5.2 155.19 -6.99 1.79 -2.02 
10 Nimbione -6.48 17.84 -6.78 0.3 0.04 
11 Nimbocinolide -4.99 220.62 -7.67 2.68 -4.79 
12 Quercitrin -2.84 8.32 -5.82 2.98 -4.81 
13 Vepnin -6.79 10.49 -7.69 0.89 -0.85 
14 Saquinavir -6.49 17.36 -10.67 3.58 38.13 
15 Nelfinavir -3.22 4.36 -6.8 3.58 -3.48 
 
 
Fig. 2: 3D Visualization of docking analysis of 6LU7 protease binding with 1. Azadiradione 2. Nimbione 3. Vepnin 4. Saquinavir. The yellow 
dots represent hydrogen bonds 
 
Table 4: Molecular docking analysis of bioactive molecules from Azadirachta indica against 2GTB 






Torsional energy Internal 
energy 
1 Azadiradione -6.96 7.88 -7.86 0.89 -1.2 
2 Beta-sitosterol -6.63 22.94 -8.42 2.09 -1.24 
3 Epiazadiradione -7.13 5.9 -8.03 0.89 -1.31 
4 Epoxyazadiradione -6.69 12.44 -7.59 0.89 -1.09 
5 Kaempferol -5.22 149.3 -6.71 1.49 -1.38 
6 Meldenin -6.44 19.0 -7.63 1.19 -1.68 
7 Myricetin -5.06 194.42 -7.15 2.09 -2.02 
8 Nimbaflavone -5.93 44.69 -8.32 2.39 -1.96 
9 Nimbinene -4.68 370.49 -6.47 1.79 -2.04 
10 Nimbione -6.66 13.06 -6.96 0.3 0.04 
11 Nimbocinolide -5.3 129.63 -7.99 2.68 -4.28 
12 Quercitrin -5.63 75.17 -8.61 2.98 -4.09 
13 Vepnin -7.11 6.15 -8.0 0.89 -0.86 
14 Saquinavir -6.89 8.92 -10.47 3.58 38.02 
15 Nelfinavir -5.42 106.48 -9.0 3.58 -3.49 
 
 
Fig. 3: 3D Visualization of docking analysis of 2GTB protease binding with 1. Azadiradione 2. Beta-sitosterol 3. Epiazadiradione 4. 
Epoxyazadiradione 5. Meldenin 6. Nimbione 7. Vepnin 8. Saquinavir. The yellow dots represent hydrogen bonds
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Out of 13 compounds evaluated from Azadirachta indica the binding 
energies more than the upper threshold limit, of-6Kcal/mol were 
selected. The binding affinity for protease 2GTB ranged between-
4.68 (Nimbinene) to-7.13 (Epiazadiradione). The binding affinities 
for protease 2GTB were-6.96,-7.13,-6.69,-6.44,-6.66,-5.63,-7.11,-6.89 
for Azadiradione, Beta-sitosterol, Epoxyazadiradione, Meldenin, 
Nimbione, and Vepnin respectively. The binding energy of 
Saquinavir was-6.89. The binding affinities of these compounds 
were reasonably compared well with that of Saquinavir. Nelfinavir 
showed binding energies lesser than the threshold limit with all the 
3 proteases. 
Fig. 4 showed 2D visualization of binding sites of various bioactive 
compounds from Azadirachta indica to the active sites of 
coronavirus proteases 6Y2E, 6LU7, and 2GTB. The 3D and 2D 
visualization results clearly indicated that the ligand molecules bind 
to the active site of the coronavirus proteases and therefore, it could 
be expected to inhibit the enzyme activity and stopped the 
replication of the virus. Bioactive compounds (ligands) 
Azadiradione, Beta-sitosterol, Epoxyazadiradione, Meldenin, 
Nimbione, and Vepnin responded well against the Coronavirus 
proteases 6Y2E, 6LU7 and 2 GTB. 
Azadirachtin and Epoxyazadiradione had significantly higher or 
similar binding efficacy against their SARS-CoV-2 targets 6VSB 
(surface spike glycoprotein) 6Y84 (main Protease) and 6M71 (RNA 
dependent RNA polymerase) when compared to 
Lopinavir/Ritonavir and Remdesivir [19]. Shanmuga Subramanian 
in 2020 showed that the binding energies obtained from the docking 
of 6LU7 with Meliacinanhydride, Nimocinol, Isomeldenin, 
Nimbolide, Zafaral, Nimbandiol, Nimbin, Nimbinene, 
Desacetylnimbin were-14.3,-12.4,-12.3,-12.2,-11.9,-11.8,-11.7,-11.7,-
11.4 kcal/mol respectively. These compounds showed better 
binding energies when compared with Remdesivir and 
HydroxyCholoroquine [20]. Apart from these bioactive compounds, 
neem leaves contain other compounds like Zinc, Vitamin A, Vitamin 
B1, Vitamin B2, Vitamin B6, Vitamin C, Vitamin E, etc. which may 






Fig. 4: 2D Visualization of molecular interaction with A) 6Y2E B) 6LU7 C) 2GTB with A1. Azadiradione, A2. Beta-sitosterol, A3. 
Epiazadiradione, A4. Meldenin, A5. Nimbione, A6. Vepnin, A7. Saquinavir, B1. Azadiradione, B2. Nimbione, B3. Vepnin, C1. Azadiradione, 
C2. Beta-sitosterol, C3. Epiazadiradione, C4. Epoxyazadiradione, C5. Meldenin, C6. Nimbione, C7. Vepnin, C8. Saquinavir 
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The use of natural products for the disease cure and prevention is 
increasing all over the world because of its lesser side effects. 
Azadirachta indica is a common tree that will be present in all the 
houses and its leaves, bark, trunk; seeds had been already known for 
its antiviral and antibacterial properties around the world. The 
present study also proved that the bioactive compounds like 
Azadiradione, Beta-sitosterol, Epoxyazadiradione, Meldenin, 
Nimbione, and Vepnin from Azadirachta indica had antiviral property 
against Coronavirus. However, further in vitro and in vivo tests are 
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